Monitoring Protocols for Cochlear Toxicity
Overview
Authors
Affiliations
The need for monitoring hearing and auditory function during drug therapy and other treatments that have the potential to cause hearing loss is well documented. Besides the main purpose of ototoxic monitoring, which is to provide feedback to the attending physician about the effects the treatment is having on the auditory system, it is also helpful in setting expectations for the patient and his/her family about the communication issues that may result from the drug therapy. This article will review tests available to an audiologist, both subjective and objective, that can be used to effectively monitor hearing levels and auditory function during treatment. Published guidelines and various ototoxic monitoring protocols are reviewed regarding tests administered, what constitutes a significant change in test results and how these findings are reported, and the impact significant changes may have on the course of treatment. Test protocols from different institutions are compared for both similarities and contrasts. Effective scheduling and test location are key to a successful monitoring program. Finally, the need to streamline ototoxic monitoring of hearing and auditory function to reduce test time and make it less stressful and tiresome on the patient will be considered.
The Impact of Monoclonal Antibody Usage on Hearing Outcomes: A Systematic Review.
Arya P, Salmeron Y, Quimby A, Wong K, Brant J, Hwa T Laryngoscope. 2024; 135(2):491-506.
PMID: 39268884 PMC: 11725704. DOI: 10.1002/lary.31763.
Ototoxicity: a high risk to auditory function that needs to be monitored in drug development.
Pasdelou M, Byelyayeva L, Malmstrom S, Pucheu S, Peytavy M, Laullier H Front Mol Neurosci. 2024; 17:1379743.
PMID: 38756707 PMC: 11096496. DOI: 10.3389/fnmol.2024.1379743.
Paken J, Govender C, Pillay M, Feyasa M, Sewram V PLoS One. 2023; 18(4):e0283639.
PMID: 37014872 PMC: 10072443. DOI: 10.1371/journal.pone.0283639.
Noise-induced hearing disorders: Clinical and investigational tools.
Le Prell C, Clavier O, Bao J J Acoust Soc Am. 2023; 153(1):711.
PMID: 36732240 PMC: 9889121. DOI: 10.1121/10.0017002.
Paken J, Govender C, Pillay M, Sewram V BMC Health Serv Res. 2022; 22(1):791.
PMID: 35717191 PMC: 9206275. DOI: 10.1186/s12913-022-08099-8.